FEMIVIA Trademark

Trademark Overview

On Friday, December 23, 2016, a trademark application was filed for FEMIVIA with the United States Patent and Trademark Office. The USPTO has given the FEMIVIA trademark a serial number of 87279934. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 16, 2019. This trademark is owned by Endoceutics, Inc.. The FEMIVIA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the prevention and treatment of breast and uterine cancer, Alzheimer's disease, medical conditions related to menopause, bone loss, muscle loss, type 2 diabetes, fat accumulation, osteoporosis, hot flashes, skin atrophy, memory loss, and cognition loss
femivia

General Information

Serial Number87279934
Word MarkFEMIVIA
Filing DateFriday, December 23, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 16, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2017

Trademark Statements

Goods and Servicespharmaceutical preparations for the prevention and treatment of breast and uterine cancer, Alzheimer's disease, medical conditions related to menopause, bone loss, muscle loss, type 2 diabetes, fat accumulation, osteoporosis, hot flashes, skin atrophy, memory loss, and cognition loss

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 7, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEndoceutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressQuebec City, Québec G1V4M7
CA
Party NameEndoceutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressQuebec City, Québec G1W2J5
CA

Trademark Events

Event DateEvent Description
Monday, December 16, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 16, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 5, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 5, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 14, 2019EXTENSION 3 GRANTED
Tuesday, May 14, 2019EXTENSION 3 FILED
Tuesday, May 14, 2019TEAS EXTENSION RECEIVED
Wednesday, November 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 12, 2018EXTENSION 2 GRANTED
Monday, November 12, 2018EXTENSION 2 FILED
Monday, November 12, 2018TEAS EXTENSION RECEIVED
Wednesday, May 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 14, 2018EXTENSION 1 GRANTED
Monday, May 14, 2018EXTENSION 1 FILED
Monday, May 14, 2018TEAS EXTENSION RECEIVED
Tuesday, November 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 30, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 5, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 4, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 4, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 1, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 1, 2017NON-FINAL ACTION E-MAILED
Wednesday, March 1, 2017NON-FINAL ACTION WRITTEN
Tuesday, February 28, 2017ASSIGNED TO EXAMINER
Saturday, January 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 27, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

femivia loss accumulation diabetes muscle osteoporosis type flashes cognition memory atrophy